Katarzyna Dulna

Katarzyna Dulna has held various positions in the clinical research field, starting as a Clinical Research Associate at Eli Lilly and Company. Katarzyna later worked as a Senior Clinical Research Associate at Pfizer before moving on to CLINMARK where Katarzyna currently serves as the Chief Medical Officer. In their current role, Katarzyna oversees various aspects of clinical development and operations, ensuring clinical trials are conducted in accordance with goals, timelines, and quality standards. Katarzyna also plays a key role in business development and collaboration with internal and external medical experts. Throughout their career, Katarzyna has demonstrated strong leadership, management, and quality assurance skills in the clinical research industry.